arrow
Y

Yohei Doi

university of north carolina school of medicine
H指数:92
被引数:3.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comorbidities and Patient Outcomes in Carbapenem-Resistant Gram-negative Bacterial Infections

碳青霉烯耐药革兰阴性菌感染中的合并症与患者结局

2026-09-150
OAAI
Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan

难治性耐药(DTR)、治疗及结果:日本IMP型碳青霉烯酶占主导的碳青霉烯耐药肠杆菌科细菌感染

2026-06-020
PRE
A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol

ADC β-内酰胺酶Ω环中的Val292替换与丙氨酸重复(ADUP)相结合,导致对包括cefiderocol在内的先进β-内酰胺类抗生素的敏感性降低

mBio
IF4.7
2026-05-130
PRE
Early best available antibiotic therapy for multidrug-resistant gram-negative bloodstream infections: a target trial emulation

多药耐药革兰阴性菌血流感染的早期最佳可用抗生素治疗:目标试验模拟

2026-01-010
OAAI
Clinical Outcomes of Carbapenem-Resistant versus Carbapenem-Susceptible Pseudomonas aeruginosa Infections in Japan: A Multicenter Matched Case-Control Study by the Multi-Drug Resistant Organisms Clinical Research Network (MDRnet)

日本临床中,对碳青霉烯耐药与敏感的铜绿假单胞菌感染的临床结局比较:多药耐药菌临床研究网络(MDRnet)的多中心匹配病例对照研究

2026-01-010
OAAI
Features of Carbapenem-resistant Gram-negative Bacterial Infections in Japan Based on the Setting of Onset

基于发病场所的日本碳青霉烯耐药革兰氏阴性菌感染特征

2025-10-010
OAAI
Exploring the complex interplay of polymyxin resistance mechanisms, lipid A variations, and virulence factors in Escherichia coli and Klebsiella pneumoniae

探索大肠杆菌和肺炎克雷伯菌中多粘菌素耐药机制、脂质A变异和毒力因子的复杂相互作用

2025-09-010
OAAI
A network analysis of carbapenem-resistant Klebsiella pneumoniae among healthcare facilities

医疗设施中耐碳青霉烯肺炎克雷伯菌的网络分析

2025-07-290
OA
Safety and Efficacy of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE) for Mild COVID-19: A Double-Blind, Placebo-Controlled, Randomized Comparative Trial

无麻黄碱生物碱的麻黄提取物(EFE)对轻度COVID-19的安全性与有效性:一项双盲、安慰剂对照、随机比较试验

2025-03-121
OA
Molecular epidemiology and patient outcome of carbapenem-resistant Enterobacterales, Pseudomonas aeruginosa and Acinetobacter baumannii in Japan: a multicenter study from MultiDrug-Resistant organisms clinical research network
2025-03-060
OAAI
Global emergence of Carbapenem-resistant Hypervirulent Klebsiella pneumoniae driven by an IncFIIK34 KPC-2 plasmid

由IncFIIK34 KPC-2质粒驱动的超毒力肺炎克雷伯菌碳青霉烯耐药性的全球出现

2025-03-012
OAAI